Publications PEVNET

Link to PEVNET consortium group of investigators cited/acknowledged in the publications


Articles in scientific journals:

Alidjinou EK, Chehadeh W, Weill J, Vantyghem MC, Stuckens C, Decoster A, Hober C, Hober D. Monocytes of Patients with Type 1 Diabetes Harbour Enterovirus RNA. Eur J Clin Invest. 2015 Jun 24.

Alidjinou EK, Sané F, Engelmann I, Hober D. Serum-Dependent Enhancement of Coxsackievirus B4-Induced Production of IFNα, IL-6 and TNFα by Peripheral Blood Mononuclear Cells. J Mol Biol. 2013 Dec 13;425(24):5020-31.

Alidjinou EK, Sané F, Bertin A, Caloone D, Hober D. Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine. Antiviral Res. 2015 Apr;116:51-4.

Alidjinou EK, Sané F, Engelmann I, Geenen V, Hober D. Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes. Discov Med. 2014 Nov;18(100):273-82.

Alidjinou EK, Sané F, Trauet J, Copin MC, Hober D. Coxsackievirus B4 Can Infect Human Peripheral Blood-Derived Macrophages. Viruses. 2015 Nov 24;7(11):6067-79.

Anagandula M, Richardson SJ, Oberste MS, Sioofy-Khojine A, Hyoty H, Morgan NG, Korsgren O and Frisk G. Infection of Human Islets of Langerhans With Two Strains of Coxsackie B Virus Serotype 1: Assessment of Virus Replication, Degree of Cell Death and Induction of Genes Involved in the Innate Immunity Pathway. J Med Virol. 2014 Aug;86(8):1402-11.

Angulo I, Vadas O, Garçon F, Banham-Hall E, Plagnol V, Leahy TR, Baxendale H, Coulter T, Curtis J, Wu C, Blake-Palmer K, Perisic O, Smyth D, Maes M, Fiddler C, Juss J, Cilliers D, Markelj G, Chandra A, Farmer G, Kielkowska A, Clark J, Kracker S, Debré M, Picard C, Pellier I, Jabado N, Morris JA, Barcenas-Morales G, Fischer A, Stephens L, Hawkins P, Barrett JC, Abinun M, Clatworthy M, Durandy A, Doffinger R, Chilvers ER, Cant AJ, Kumararatne D, Okkenhaug K, Williams RL, Condliffe A, Nejentsev S. Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science. 2013 Nov 15; 342 (6160):866-71.

Arif S, Leete P, Nguyen V, Marks K, Nor NM, Estorninho M, Kronenberg-Versteeg D, Bingley PJ, Todd JA, Guy C, Dunger DB, Powrie J, Willcox A, Foulis AK, Richardson SJ, de Rinaldis E, Morgan NG, Lorenc A, Peakman M. (2014) Diabetes. Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes. Diabetes. 2014 Nov;63(11):3835-45.

Campbell-Thompson ML, Atkinson MA, Butler AE, Chapman NM, Frisk G, Gianani R, Giepmans BN, von Herrath MG, Hyöty H, Kay TW, Korsgren O, Morgan NG, Powers AC, Pugliese A, Richardson SJ, Rowe PA, Tracy S, In’t Veld PA. The diagnosis of insulitis in human type 1 diabetes. Diabetologia. 2013 Nov;56(11):2541-3.

Collison JL, Carlin LM, Eichmann M, Geissmann F, Peakman M. Heterogeneity in the Locomotory Behavior of Human Monocyte Subsets over Human Vascular Endothelium In Vitro. J Immunol. 2015 Aug 1;195(3):1162-70.

Dotta F, Sebastiani G. Enteroviral infections and development of type 1 diabetes: The Brothers Karamazov within the CVBs. Diabetes. 2014 Feb;63(2):384-6.

Eichmann M, de Ru A, van Veelen PA, Peakman M, Kronenberg-Versteeg D. Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including HLA-B*39:06. Tissue Antigens. 2014 Oct;84(4):378-88.

Elmastour F, Jaidane H, Aguech-Oueslati L, Benkahla MA, Aouni M, Gharbi J, Sane F, Hober D. Immunoglobulin G-dependent enhancement of the infection with Coxsackievirus B4 in a murine system. Virulence. 2016 Jul 3;7(5):527-35.

Estorninho M, Gibson VB, Kronenberg-Versteeg D, Liu YF, Ni C, Cerosaletti K, Peakman M: A novel approach to tracking antigen-experienced CD4 T cells into functional compartments via tandem deep and shallow TCR clonotyping. J Immunol 2013;191:5430-5440

Gibson VB, Nikolic T, Pearce VQ, Demengeot J, Roep BO, Peakman M. Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanised model. Clin Exp Immunol. 2015 Jul 22.

Goffard A, Alidjinou EK, Sané F, Choteau L, Bouquillon C, Caloone D, Lobert P, Hober D. Antibodies enhance the infection of phorbol-ester-differentiated human monocyte-like cells with coxsackievirus B4. Microbes Infect. 2013 Jan;15(1):18-27.

Gomez-Tourino I, Arif S, Eichmann M, Peakman M. T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive review. J Autoimmun. 2016 Jan;66:7-16.

Grieco FA, Sebastiani G, Spagnuolo I, Patti A, Dotta F. Immunology in the clinic review series; focus on type 1 diabetes and viruses: how viral infections modulate beta cell function. Clin Exp Immunol. 2012 Apr;168(1):24-9.

Hansson SF, Korsgren S, Pontén F, Korsgren O. Enteroviruses and the pathogenesis of type 1 diabetes revisited: cross-reactivity of enterovirus capsid protein (VP1) antibodies with human mitochondrial proteins. J Pathol. 2013 Apr;229(5):719-28.

Hansson SF, Korsgren S, Pontén F, Korsgren O. Detection of enterovirus in the islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry? Diabetologia. 2013 Dec 19.

von Herrath M, Peakman M, Roep B. Progress in immune-based therapies for type 1 diabetes. Clin Exp Immunol. 2013 May;172(2):186-202.

Hober D and Alidjinou EK. Enteroviral pathogenesis of type 1 diabetes: queries and answers. Curr opin infect dis 2013 Jun;26(3):263-9.

Hober D, Sane F, Jaïdane H, Riedweg K, Goffard A, Desailloud R. Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes. Clin Exp Immunol. 2012 Apr;168(1):47-51.

Hodik M, Lukinius A, Korsgren O, Frisk G. Tropism Analysis of Two Coxsackie B5 Strains Reveals Virus Growth in Human Primary Pancreatic Islets but not in Exocrine Cell Clusters In Vitro. Open Virol J. 2013 Apr 5;7:49-56.

Hodik M, Skog O, Lukinius A, Isaza-Correa JM, Kuipers J, Giepmans BN, Frisk G.

Enterovirus infection of human islets of Langerhans affects β-cell function resulting in disintegrated islets, decreased glucose stimulated insulin secretion and loss of Golgi structure. BMJ Open Diabetes Res Care. 2016 Aug 10;4(1):e000179.

Honkanen H, Oikarinen S, Peltonen P, Simell O, Ilonen J, Veijola R, Knip M, Hyöty H. Human rhinoviruses including group C are common in stool samples of young Finnish children. J Clin Virol. 2013 Mar;56(3):250-4.

Honkanen H, Oikarinen S, Tolonen O, Ruokoranta T, Pulkki M, Laitinen O, Tauriainen S, Korpela S, Lappalainen M, Vuorinen T, Haapala A-M, Veijola R, Ilonen J, Simell O, Ilonen J, Knip M, Hyöty H. Human enterovirus 71 strains in the background population and in hospital patients in Finland. J Clin Virol. 2013 Apr;56(4):348-53.

Honkanen H, Oikarinen S, Nurminen N, Laitinen OH, Huhtala H, Lehtonen J, Ruokoranta T, Hankaniemi MM, Lecouturier V, Almond JW, Tauriainen S, Simell O, Ilonen J, Veijola R, Viskari H, Knip M, Hyöty H. Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity.Diabetologia. 2017 Mar;60(3):424-431.

Hopfgarten J, Stenwall PA, Wiberg A, Anagandula M, Ingvast S, Rosenling T, Korsgren O, Skog O. Gene expression analysis of human islets in a subject at onset of type 1 diabetes. Acta Diabetol. 2013 Apr 27.

Hyöty H. Viruses in type 1 diabetes. Pediatr Diabetes. 2016 Jul;17 Suppl 22:56-64.

Hyöty H and Knip M. Silmukka kiristyy enterovirusten ymparillä. Milloin diabetekseen saadaan rokote? Duodecim 2014;130(19):1903–5. 13.10.2014

Hämäläinen S, Nurminen N, Ahlfors H, Oikarinen S, Sioofy-Khojine AB, Frisk G, Oberste MS, Lahesmaa R, Pesu M, Hyöty H. Coxsackievirus B1 reveals strain specific differences in plasmacytoid dendritic cell mediated immunogenicity. J Med Virol, Article first published online: 20 Feb, 2014

Jaïdane H, Caloone D, Lobert PE, Sane F, Dardenne O, Naquet P, Gharbi J, Aouni, M, Geenen V, Hober D. Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factor. J Virol. 2012 Oct;86(20):11151-62.

Kallionpää H, Elo LL, Laajala E, Mykkänen J, Ricaño-Ponce I, Vaarma M, Laajala TD, Hyöty H, Ilonen J, Veijola R, Simell T, Wijmenga C, Knip M, Lähdesmäki H, Simell O, Lahesmaa R. Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility. Diabetes. 2014 Feb 18. Epub ahead of print

Knight, R. R., G. Dolton, D. Kronenberg-Versteeg, M. Eichmann, M. Zhao, G. C. Huang, K. Beck, D. K. Cole, A. K. Sewell, A. Skowera, and M. Peakman. A distinct immunogenic region of glutamic acid decarboxylase 65 is naturally processed and presented by human islet cells to cytotoxic CD8 T cells. Clin Exp Immunol. 2015 Jan;179(1):100-7.

Koho T, Koivunen MLR, Oikarinen S, Kummola L, Mäkinen S, Mähönen A, Sioofy Khojine AB, Marjomäki V, Kazmertsuk A, Junttila I, Kulomaa MS, Hyöty H, Hytönen VP, Laitinen OH. Coxsackievirus B3 VLPs purified by ion exchange chromatography elicit strong immune responses in mice. Antiviral Res. 2014 Apr;104:93-101.

Kondrashova A, Hyöty H. Role of Viruses and Other Microbes in the Pathogenesis of Type 1 Diabetes. Int Rev Immunol. 2014 Mar 10.

Korsgren S, Molin Y, Salmela K, Lundgren T, Melhus A, Korsgren O. On the etiology of type 1 diabetes: a new animal model signifying a decisive role for bacteria eliciting an adverse innate immunity response. Am J Pathol. 2012 Nov;181(5):1735-48.

Kramná L, Kolárová K,1 Oikarinen S, Pursiheimo JP, Ilonen J, Simell O, Knip M, Veijola R, Hyöty H and Cinek O. Gut Virome Sequencing in Children With Early Islet Autoimmunity. Diabetes Care. 2015 May;38(5):930-3.

Krogvold L, Edwin B, Buanes T, Frisk G, Skog O, Anagandula M, Korsgren O, Undlien D, Eike M, Richardson SJ, Leete P, Morgan NG, Oikarinen S, Oikarinen M, Laiho JE, Hyöty H, Ludvigsson J, Hanssen KF, Dahl-Jørgensen K. Detection of a low-grade enteroviral infection in the islets of Langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 2015 May;64(5):1682-7.

Krogvold L, Edwin B, Buanes T, Ludvigsson J, Korsgren O, Hyöty H, Frisk G, Hanssen KF, Dahl-Jørgensen K. Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study. Diabetologia. 2014 Apr;57(4):841-3.

Krogvold L, Skog O, Sundström G, Edwin B, Buanes T, Hanssen KF, Ludvigsson J, Grabherr M, Korsgren O, Dahl-Jørgensen K. Function of Isolated Pancreatic Islets From Patients at Onset of Type 1 Diabetes: Insulin Secretion Can Be Restored After Some Days in a Nondiabetogenic Environment In Vitro: Results From the DiViD Study. Diabetes. 2015 Jul;64(7):2506-12.

Krogvold L, Wiberg A, Edwin B, Buanes T, Jahnsen F L, Hanssen K F, Larsson E, Korsgren O, Skog O, Dahl-Jørgensen K. Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes. Diabetologia. 2016 Mar; 59(3):492-501.

Laiho JE, Oikarinen Sa, Oikarinen M, Larsson PG, Stone VM, Hober D, Oberste S, Flodström-Tullberg M, Isola J, Hyöty H. Application of bioinformatics in probe design enables detection of enteroviruses on different taxonomic levels by advanced in situ hybridization technology. J Clin Virol 69 (2015) 165–171.

Laiho JE, Oikarinen S, Oikarinen M, Larsson PG, Stone VM, Hober D, Oberste S, Flodström-Tullberg M, Isola J, Hyöty H. Application of bioinformatics in probe design enables detection of enteroviruses on different taxonomic levels by advanced in situ hybridization technology. J Clin Virol. 2015 Aug;69:165-71.

Laiho JE, Oikarinen M, Richardson SJ, Frisk G, Nyalwidhe J, Burch TC, Morris MA, Oikarinen S, Pugliese A, Dotta F, Campbell-Thompson M, Nadler J, Morgan NG, Hyöty H; JDRF nPOD-Virus Group. Relative sensitivity of immunohistochemistry, multiple reaction monitoring mass spectrometry, in situ hybridization and PCR to detect Coxsackievirus B1 in A549 cells. J Clin Virol. 2016 Apr;77:21-8.

Laitinen OH, Honkanen H, Pakkanen O, Oikarinen S, Pulkki, MM, Huhtala H, Ruokoranta T, Lecouturier V, André P, Harju R, Almond JW, Simell T, Simell O, Ilonen J, Veijola R, Knip M, Hyöty H. Coxsackievirus B1 is associated with the induction of beta-cell autoimmunity that portends type 1 diabetes. Diabetes. 2014 Feb;63(2):446-55.

Laitinen, O., Svedin, E., Kapell, S., Nurminen, A., Hytönen, V., Flodström-Tullberg M. Enteroviral proteases: Structure, Host interactions, and Pathogenecity. Rev Med Virol. 2016 Jul;26(4):251-67.

Larsson PG1, Lakshmikanth T, Laitinen OH, Utorova R, Jacobson S, Oikarinen M, Domsgen E, Koivunen MR, Chaux P, Devard N, Lecouturier V, Almond J, Knip M, Hyöty H, Flodström-Tullberg M. Diabetologia. A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models. Diabetologia. 2015 Feb;58(2):346-54.

Leete P, Willcox A, Krogvold L, Dahl-Jørgensen K, Foulis AK, Richardson SJ, Morgan NG. Differential Insulitic Profiles Determine the Extent of β-Cell Destruction and the Age at Onset of Type 1 Diabetes. Diabetes. 2016 May;65(5):1362-9.

Lind K, Richardson SJ, Leete P, Morgan NG, Korsgren O, Flodström-Tullberg M. Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets. J Virol. 2013 Jul;87(13):7646-54.

Lind K, Svedin E, Domsgen E, Kapell S, Laitinen O, Moll M, Flodström-Tullberg M. Coxsackievirus counters the host innate immune response by blocking type III interferon expression. J Gen Virol. 2016 Jun;97(6):1-12

Lind K, Svedin E, Utorova R, Stone VM, Flodström-Tullberg M. Type III Interferons are Expressed by Coxsackievirus Infected Human Primary Hepatocytes and Regulate Hepatocyte Permissiveness to Infection. Clin Exp Immunol. 2014 Sep;177(3):687-95.

Marroqui Esclapez L, Lopes M, Dos Santos RS, Grieco FA, Roivainen M, Richardson SJ, Morgan NG, Op de Beeck A, Eizirik DL. Differential cell autonomous responses determine the outcome of coxsackievirus infections in murine pancreatic α and β cells. Elife. 2015 Jun 10;4.

Morgan NG, Leete P, Foulis AK, Richardson SJ. Islet Inflammation in Human Type 1 Diabetes. IUBMB Life 2014 Nov;66(11):723-34.

Morgan NG, Richardson SJ. Changing perspectives on the progression of type 1 diabetes. Practical Diabetes (accepted in April 2016).

Morgan NG, Richardson SJ. Enteroviruses as causative agents in type 1 diabetes: loose ends or lost cause? Trends Endocrinol Metab. 2014 Dec;25(12):611-9.

Nurminen N, Oikarinen S, Hyöty H. Virus infections as potential targets of preventive treatments for type 1 diabetes. Rev Diabet Stud. 2012 Winter;9(4):260-71.

Oikarinen M, Tauriainen S, Oikarinen S, Honkanen T, Collin P, Rantala I, Mäki M, Kaukinen K, Hyöty H. Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes. 2012 Mar;61(3):687-91.

Oikarinen S, Tauriainen S, Hober D, Lucas B, Vazeou A, Sioofy Khojine A, Bozas E, Muir P, Honkanen H, Ilonen J, Knip M, Keskinen P, Saha MT, Huhtala H, Stanway G, Bartsocas CS, Ludvigsson J, Taylor K, Hyöty H and the VirDiab study group. Virus Antibody Survey in Different European Populations Indicates Risk Association Between Coxsackievirus B1 and Type 1 Diabetes. Diabetes. 2014 Feb;63(2):655-62.

Oikarinen M, Tauriainen S, Oikarinen S, Honkanen T, Collin P, Rantala I, Mäki M, Kaukinen K, Hyöty H. Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes 61:687-91, 2012.

Peakman M. Immunological pathways to β-cell damage in Type 1 diabetes. Diabet Med. 2013 Feb;30(2):147-54.

Plagnol V, Curtis J, Epstein M, Mok KY, Stebbings E, Grigoriadou S, Wood NW, Hambleton S, Burns SO, Thrasher AJ, Kumararatne D, Doffinger R, Nejentsev S. A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics. 2012 Nov 1; 28 (21):2747-54

Richardson SJ, Leete P, Bone AJ, Foulis AK, Morgan NG. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia. 2013 Jan;56(1):185-93.

Richardson S.J., Horwitz M.S. Is Type 1 diabetes ‘going viral’? Invited commentary. Diabetes 2014 Jul;63(7):2203-5.

Richardson, S.J., Leete, P., Dhayal, S., Russell, MA., Oikarinen, M., Laiho, J., Svedin, S., Lind, K., Rosenling, T., Chapman, N., Bone, A.J., Foulis, A.K., Frisk, G., Flodström-Tullberg, M., Hober, D., Hyoty, H., Pugliese, A., Morgan, N.G. Detection of enterovirus in islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry? Reply to Hansson SF, Korsgren S, Pontén F et al [letter]. Diabetologia 2014; 57(3), 647-9.

Richardson, S.J., Morgan, N.G., Foulis, A.K. Pancreatic Pathology in Type 1 Diabetes Mellitus. Endocr Pathol. 2014 Mar;25(1):80-92.

Richardson SJ, Leete P, Dhayal S, Russell MA, Oikarinen M, Laiho JE, Svedin E, Lind K, Rosenling T, Chapman N, Bone AJ; The nPOD-V Consortium, Foulis AK, Frisk G, Flodstrom-Tullberg M, Hober D, Hyoty H, Morgan NG. Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas. Diabetologia. 2014 Feb;57(2):392-401.

Richardson SJ, Horwitz MS. miR, miR in the Cell, Does the Virus Control Them All? Diabetes. 2016 Apr;65(4):823-5.

Russell MA, Cooper AC, Dhayal S, Morgan NG. Differential effects of interleukin-13 and interleukin-6 on Jak/STAT signaling and cell viability in pancreatic β-cells. Islets. 2013 Mar-Apr;5(2):95-105.

Russell M.A, Morgan N.G, 2014, The impact of anti-inflammatory cytokines on the pancreatic β-cell. Islets, 2014;6(3):e950547.

Sane F, Alidjinou EK, Kacet N, Moukassa D, Charlet C, Ebatetou-Ataboho E, Ngoulou W, Badia-Boungou F, Romond MB, Hober D. Human milk can neutralize coxsackievirus B4 in vitro. J Med Virol 2013 May;85(5):880-7.

Sane F, Caloone D, Gmyr V, Engelmann I, Belaich S, Kerr-Conte J, Pattou F, Desailloud R, Hober D. Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates. Cell Mol Life Sci. 2013 Jun 18. Nov;70(21):4169-80.

Sarmiento L, Frisk G, Anagandula M, Cabrera-Rode E, Roivainen M, Cilio CM. Expression of innate immunity genes and damage of primary human pancreatic islets by epidemic strains of echovirus: implication for post-virus islet autoimmunity. PLoS One. 2013 Nov 1;8(11):e77850.

Sarmiento L, Medina A, Aziz K, Anagandula M, Cabrera-Rode E, Fex M, Frisk G, Cilio CM. Differential effects of three echovirus strains on cell lysis and insulin secretion in beta cell derived lines. J Med Virol. 2016 Jun;88(6):971-8.

Schulte BM, Gielen PR, Kers-Rebel ED, Prosser AC, Lind K, Flodström-Tullberg M, Tack CJ, Elving LD, Adema GJ. Enterovirus explosure uniquely discriminates type 1 diabetes with a homozygous from a heterozygous MDA5/IFIH1 A946T genotype. Viral Immunol. 2016 Sep;29(7):389-97.

Sebastiani G, Nigi L, Spagnuolo I, Morganti E, Fondelli C, Dotta F. MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications. J Biomed. Sci. Engin. 2013 6: 58-64.

Sebastiani G, Po A, Miele E, Ventriglia G, Ceccarelli E, Bugliani M, Marselli L, Marchetti P, Gulino A, Ferretti E, Dotta F. MicroRNA-124a is hyperexpressed in type-2 diabetic human pancreatic islets and negatively regulates insulin secretion. Acta Diabetol. 2015 Jun;52(3):523-30.

Skog O., Korsgren O., Frisk G. Modulation of Innate Immunity in Human Pancreatic Islets Infected with Enterovirus in vitroJ Med Virol. 2011 Apr;83(4):658-64.

Skog O, Korsgren S, Melhus A, Korsgren O. Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease. Curr Opin Endocrinol Diabetes Obes. 2013 Apr;20(2):118-23.

Skog O, Korsgren S, Wiberg A, Danielsson A, Edwin B, Buanes T, Krogvold L, Korsgren O, Dahl-Jørgensen K. Expression of Human Leukocyte Antigen Class I in Endocrine and Exocrine Pancreatic Tissue at Onset of Type 1 Diabetes. Am J Pathol 2015, 185: 129-138.

Skog O, Korsgren S, Melhus A, Korsgren O. Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease. Curr Opin Endocrinol Diabetes Obes. 2013 Apr;20(2):118-23.

Skog O, Ingvast S, Korsgren O. Evaluation of RT-PCR and immunohistochemistry as tools for detection of enterovirus in the human pancreas and islets of Langerhans. J Clin Virol. 2014 Oct;61(2):242-7.

Skowera, A., K. Ladell, J. E. McLaren, G. Dolton, K. K. Matthews, E. Gostick, D. Kronenberg-Versteeg, M. Eichmann, R. R. Knight, S. Heck, J. Powrie, P. J. Bingley, C. M. Dayan, J. J. Miles, A. K. Sewell, D. A. Price, and M. Peakman. Beta-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure. Diabetes. 2015 Mar;64(3):916-25.

Spagnuolo I, Patti A, Sebastiani G, Nigi L, Dotta F. The case for virus-induced type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2013 Aug;20(4):292-8.

Taniguchi K, Russell MA, Richardson SJ, Morgan NG. The subcellular distribution of cyclin-D1 and cyclin-D3 within human islet cells varies according to the status of the pancreas donor. Diabetologia 2015 Sep;58(9):2056-63.

Valle A, Giamporcaro GM, Scavini M, Stabilini A, Grogan P, Bianconi E, Sebastiani G, Masini M, Maugeri N, Porretti L, Bonfanti R, Meschi F, De Pellegrin M, Lesma A, Rossini S, Piemonti L, Marchetti P, Dotta F, Bosi E, Battaglia M. Reduction of circulating neutrophils precedes and accompanies type 1 diabetes. Diabetes. 2013 Jun;62(6):2072-7.

Wagner FF, Lundh M, Kaya T, McCarren P, Zhang YL, Chattopadhyay S, Gale JP, Galbo T, Fisher SL, Meier BC, Vetere A, Richardson S, Morgan NG, Christensen DP, Gilbert TJ, Hooker JM, Leroy M, Walpita D, Mandrup-Poulsen T, Wagner BK, Holson EB. An Isochemogenic Set of Inhibitors To Define the Therapeutic Potential of Histone Deacetylases in β-Cell Protection. ACS Chem Biol. 2016 Feb 19;11(2):363-74.

Wiberg A, Granstam A, Ingvast S, Härkönen T, Knip M, Korsgren O, Skog O. Characterization of human organ donors testing positive for type 1 diabetes-associated autoantibodies. Clin Exp Immunol. 2015 Aug 27.